Oklo Inc. (OKLO) and NuScale Power Corporation (SMR) stand out among advanced nuclear names where investors see potential for compact reactors to deliver steady power for data centers and AI workloads. Both remain pre-revenue, with valuations tied to licensing progress, order potential, and the prospect of an initial commercial project. This comparison suits growth-focused investors who accept extended timelines and notable swings, as well as those looking to understand how the two differ in model, regulatory standing, and sentiment.
Oklo is working on the Aurora powerhouse, a liquid-metal-cooled fast reactor suited for data centers, industrial sites, and remote areas. The company has expanded into nuclear fuel recycling and medical isotope production. A recent milestone came when its Groves Isotope Test Reactor in Texas reached first criticality less than a year after groundbreaking. Progress also continues on NRC approvals for Aurora at Idaho National Laboratory, alongside acquisitions that bolster manufacturing and sodium-handling capabilities.
High-profile ties with Meta Platforms and NVIDIA (NVDA) have supported sentiment by linking the technology to large-scale data-center needs and AI-driven engineering. Still, the stock has moved sharply. After a strong 2025 advance, shares are down roughly 45% or more in 2026 as valuations for early-stage developers faced renewed scrutiny, and short interest ranks among the highest in utilities. Wall Street keeps a Moderate Buy consensus, reflecting confidence in the path to planned 2028 operations. I also checked this using Tickeron’s AI Trend Prediction Engine to gauge current momentum.
NuScale stands apart as the only small modular reactor developer with an NRC-certified design, giving it a regulatory advantage. Its approach relies on commercially available low-enriched uranium and a network of more than 60 specialized suppliers. Key efforts include discussions between financing partner ENTRA1 Energy and the Tennessee Valley Authority on a possible power purchase agreement, plus the proposed six-module Doicești project in Romania.
Like Oklo, NuScale has seen sharp swings. Shares are down roughly 40% to 50% in 2026 even with occasional rallies linked to Big Tech nuclear interest, and the latest quarter closed with about $1.9 billion in cash, equivalents, and investments. Revenue stays minimal while losses continue, so valuation hinges on turning prospective projects into firm contracts. Analysts maintain a neutral "Hold" consensus. From what I see, the company’s near-term focus remains on securing that TVA agreement.
The clearest distinction lies in regulatory status. NuScale’s certified design offers a validated foundation, whereas Oklo is still moving through approvals for Aurora. On the business side, Oklo covers a wider scope that includes power, fuel recycling, and isotopes, while NuScale concentrates more narrowly on reactor deployment. Growth drivers reflect this split: Oklo draws on Big Tech partnerships and a vertically integrated fuel approach, whereas NuScale depends on converting the TVA opportunity and international projects into binding deals.
Recent price action shows both stocks moving together on sector headlines rather than company-specific results. Risk profiles vary—Oklo contends with elevated short interest and questions around high-assay low-enriched uranium supply, while NuScale’s 2023 project cancellation continues to influence caution on first-of-a-kind execution. In positioning terms, Oklo enjoys stronger analyst support, while NuScale’s strength rests on a certified design that may shorten the timeline to commercialization. I reviewed comparable names with Tickeron’s AI Screener to place these two in broader industry context.
Considering factors such as trend consistency, catalyst visibility, and relative positioning, the setup appears more constructive for OKLO at present. Tangible operational milestones, a broader revenue platform, and firmer analyst consensus give it an edge over NuScale’s heavier reliance on contract conversion. Both remain high-volatility, pre-revenue developers, however, so any advantage stays probabilistic. Weighing Oklo’s execution and valuation risks against NuScale’s regulatory lead remains essential before taking a position.
When evaluating volatile names like these, I often turn to Tickeron’s AI Trading Bots for additional perspective. The platform hosts hundreds of AI-powered bots that monitor and trade thousands of tickers, each with its own style, strategy, and performance data. Reviewing the curated selection of trending bots helps identify which approaches are gaining traction in the current market environment and can complement fundamental analysis of stocks such as OKLO and SMR.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Experienced trader focused on market analysis, identifying trading opportunities, and developing custom trading signals based on market trends, price action, and data-driven insights. Join my Trader Club to follow my latest analysis, trading ideas, and active signals: https://tickeron.com/app/trader-club/103/view?tab=active§ion=trades&via=john
The 10-day RSI Indicator for SMR moved out of overbought territory on September 09, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 instances where the indicator moved out of the overbought zone. In 27 of the 30 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.
The Momentum Indicator moved below the 0 level on September 11, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SMR as a result. In 71 of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 76%.
The Moving Average Convergence Divergence Histogram (MACD) for SMR turned negative on September 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In 36 of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at 88%.
SMR moved below its 50-day moving average on September 11, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for SMR crossed bearishly below the 50-day moving average on September 22, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 81%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SMR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
SMR broke above its upper Bollinger Band on September 08, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for SMR entered a downward trend on October 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 16 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +7.50% 3-day Advance, the price is estimated to grow further. Considering data from situations where SMR advanced for three days, in 196 of 248 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
The Tickeron Valuation Rating of 38 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.575) is normal, around the industry mean (5.342). P/E Ratio (0.000) is within average values for comparable stocks, (66.065). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.879). Dividend Yield (0.000) settles around the average of (0.014) among similar stocks. P/S Ratio (208.333) is also within normal values, averaging (186.943).
The Tickeron Price Growth Rating for this company is 85 (best 1 - 100 worst), indicating slightly worse than average price growth. SMR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SMR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry IndustrialMachinery